Department of Radiology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Lasers Med Sci. 1997 Oct;12(3):274-9. doi: 10.1007/BF02765109.
This study was conducted to address the question of how cancers of different histologies of the head and neck region responded to photodynamic therapy (PDT). Five human cancer cell lines were investigated: two squamous cell carcinoma lines (pharynx and tongue), mucoepidermoid carcinoma (submaxillary gland), rhabdomyosarcoma (embryonic) and adenocarcinoma (colon). The cell lines were treated with haematoporphyrin derivative (HpD) at doses of 0.78-25Mug ml(-1), with excitation of the absorbed drug by a 'black light' source (340-380 nm). An MTT assay demonstrated different PDT responses among the various cell types. On the basis of LD(50), the sensitivity of the different cell lines was ranked as follows: adenocarcinoma> squamous cell carcinoma> rhabdomyosarcoma> mucoepidermoid carcinoma. The magnitude of the LD(50) was suggested by a drug uptake study to be governed in part by cellular levels of sensitizer and in part by intrinsic cell sensitivity. This study provided information that may help to identify the histological types of head and neck cancers that would respond favourably to PDT.
本研究旨在探讨头颈部不同组织学类型的癌症对光动力疗法(PDT)的反应如何。研究调查了五个人类癌细胞系:两个鳞状细胞癌系(咽和舌)、黏液表皮样癌(颌下腺)、横纹肌肉瘤(胚胎)和腺癌(结肠)。用血卟啉衍生物(HpD)以 0.78-25μM/ml 的剂量处理细胞系,并用“黑光”源(340-380nm)激发吸收的药物。MTT 测定表明,不同细胞类型对 PDT 的反应不同。根据 LD(50),不同细胞系的敏感性排序如下:腺癌>鳞状细胞癌>横纹肌肉瘤>黏液表皮样癌。摄取研究表明,LD(50)的大小部分受细胞内敏化剂水平的控制,部分受固有细胞敏感性的控制。这项研究提供了一些信息,可能有助于确定对头颈部癌症的组织学类型,这些类型对 PDT 反应良好。